- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2014
- Public Summary Document (PSD) November 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2014 PBAC Meeting - Word
Rituximab – November 2014
Rituximab; 1,400 mg/11.7 mL; solution for subcutaneous injection; MabThera® SC
Last updated
6 March 2015